{"id":"NCT00671879","sponsor":"Meda Pharmaceuticals","briefTitle":"Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back","officialTitle":"Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2009-03","completion":"2009-03","firstPosted":"2008-05-05","resultsPosted":"2012-11-21","lastUpdate":"2012-11-21"},"enrollment":830,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lower Back Pain"],"interventions":[{"type":"DRUG","name":"Carisoprodol SR 700 mg","otherNames":["no other name"]},{"type":"DRUG","name":"Carisoprodol SR 500 mg","otherNames":["no other name"]},{"type":"DRUG","name":"Placebo","otherNames":["no other name"]}],"arms":[{"label":"Carisprodol SR 700 mg","type":"EXPERIMENTAL"},{"label":"Carisoprodol SR 500mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.","primaryOutcome":{"measure":"Subject Rated Change Relief From Starting Backache of Pain on a 100-point Visual Analog Scale","timeFrame":"baseline to 14 days","effectByArm":[{"arm":"Carisprodol SR 700 mg","deltaMin":16.4,"sd":1.3},{"arm":"Carisoprodol SR 500mg","deltaMin":15.5,"sd":1.34},{"arm":"Placebo","deltaMin":15.2,"sd":1.32}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":20},"locations":{"siteCount":73,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":281},"commonTop":["somnolence","headache","dizziness","nausea","fatigue"]}}